Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

May 12, 2018

30786_dirs_2018-05-11_87332db5-91ca-4ba6-b37e-e0527cf00bae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-05-11

Reporting Person: Magni Giovanni (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-05-11 Bio-Rad A Common Stock M 3500 $88.00 Acquired 12751 Direct
2018-05-11 Bio-Rad A Common Stock F 1918 $284.98 Disposed 10833 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-11 Non-Qualified Stock Option (right to buy) $88.00 M 3500 Disposed 2018-06-11 Bio-Rad A Common Stock (3500) Direct

Footnotes

F1: The option vested in five equal annual installments beginning on June 11, 2009.